Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.86
-1.07 (-6.72%)
At close: Mar 6, 2026, 4:00 PM EST
15.15
+0.29 (1.95%)
After-hours: Mar 6, 2026, 6:37 PM EST
Adaptive Biotechnologies Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Adaptive Biotechnologies stock have an average target of 17.78, with a low estimate of 10 and a high estimate of 22. The average target predicts an increase of 19.65% from the current stock price of 14.86.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Adaptive Biotechnologies stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 3 | 4 | 4 | 4 | 4 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +41.32% | Feb 6, 2026 |
| BTIG | BTIG | Strong Buy Maintains $21 → $22 | Strong Buy | Maintains | $21 → $22 | +48.05% | Feb 6, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $20 → $21 | Strong Buy | Maintains | $20 → $21 | +41.32% | Jan 26, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $11 → $16 | Hold | Maintains | $11 → $16 | +7.67% | Nov 11, 2025 |
| BTIG | BTIG | Strong Buy Maintains $19 → $21 | Strong Buy | Maintains | $19 → $21 | +41.32% | Nov 6, 2025 |
Financial Forecast
Revenue This Year
288.00M
from 276.98M
Increased by 3.98%
Revenue Next Year
353.44M
from 288.00M
Increased by 22.72%
EPS This Year
-0.49
from -0.39
EPS Next Year
-0.27
from -0.49
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 300.7M | 372.1M | |||
| Avg | 288.0M | 353.4M | |||
| Low | 272.8M | 332.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 8.6% | 29.2% | |||
| Avg | 4.0% | 22.7% | |||
| Low | -1.5% | 15.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.45 | -0.22 | |||
| Avg | -0.49 | -0.27 | |||
| Low | -0.51 | -0.41 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.